← Back to Clinical Trials
Recruiting NCT06569316

Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)

Trial Parameters

Condition Hematopoietic and Lymphatic System Neoplasm
Sponsor Mayo Clinic
Study Type INTERVENTIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-09-27
Completion 2027-08-31
Interventions
Biospecimen CollectionCommunication InterventionGenetic Testing

Brief Summary

This clinical trial is studying the genetic changes in cells associated with different types of cancer in Indigenous American (IA) populations in the Southwest to improve cancer screening, precision prevention, and therapeutic intervention for individual in these communities. IA tribes have much lower rates of cancer screening, have more limited access to healthcare, are more often diagnosed at later stages of disease, and have the poorest outcomes in all types of cancer when compared to any other racial and ethnic group in the United States. Due to these significant cancer health disparities, IAs have been understudied and little is known about the molecular characterization of tumors arising in IAs. Undergoing genetic testing of tumors may improve cancer outcomes in IA participants and communities.

Eligibility Criteria

Inclusion Criteria: * Male or female adults \>= 18 years of age * Cancer patient undergoing active treatment or a cancer survivor * Self-identify as Indigenous American Exclusion Criteria: * Unable to provide informed consent * Individuals who are under 18 years of age * Prisoners

Related Trials